EUVIMEDEUVIMED entdecken
Crossref

Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania

Lilian Nkinda, Eligius Lyamuya, Takamasa Ueno, Mbazi Senkoro, Sayoki Mfinanga, Benson Kidenya, Juma Kisuse, Frank Eric Hassan, Doreen Kamori, Emmanuel Nkuwi, Godfrey Barabona, Salim Masoud und 2 weitere

East African Health Research Journal · 04.11.2026 · 10 (2)

DOI: 10.24248/eahrj.v10i2.339 ↗

Kurz gefasst

Fachartikel in der Zeitschrift East African Health Research Journal, online erschienen am 04.11.2026. Verfasst von Lilian Nkinda und 13 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Coronavirus Disease 2019 has become endemic and is no longer a global health emergency. However, it remains significant for people living with HIV, whose immune dysregulation may impact antibody responses. Hence this study assessed neutralizing antibody capacity against SARS-CoV-2 variants among HIV-infected adults in Tanzania to inform sero-surveillance and pandemic readiness.

Methods

Seventy HIV-positive adults (≥18 years) were enrolled (53 vaccinated, 17 unvaccinated). These were compared with 89 individuals who were HIV negative (71 vaccinated and 18 unvaccinated). Neutralizing antibodies were quantified using a surrogate virus neutralization assay, with ≥27.7% inhibition defined as protective. Factors associated with neutralization were analyzed using modified Poisson regression (STATA v15), and group differences assessed using Kruskal-Wallis tests (Prism 9), with significance at P< .05.

Results

Our study observed a progressive decline in the proportion of participants with protective neutralizing antibodies across the SARS-CoV-2 variants, that is; 93% (65/70) for the wild-type (WT), 77% (54/70) for Delta, and 54% (38/70) for Omicron whether vaccinated or unvaccinated. Additionally, no significant difference in neutralising antibody inhibition capacity was found between participants with CD4 counts above 500 and those below, for any of the three variants, P>.9999. Also, the median percentage of neutralizing capacity among the relatively healthy HIV infected individuals (>500 CD4 count) was lower (28%) compared those who were HIV negatives (98%), within the vaccinated group (P

Zitieren

APA

Nkinda, L., Lyamuya, E., Ueno, T., Senkoro, M., Mfinanga, S., Kidenya, B., Kisuse, J., Hassan, F. E., Kamori, D., Nkuwi, E., Barabona, G., Masoud, S., Shayo, V., & Balandya, E. (2026). Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania. East African Health Research Journal, 10(2). https://doi.org/10.24248/eahrj.v10i2.339

Vancouver

Nkinda L, Lyamuya E, Ueno T, Senkoro M, Mfinanga S, Kidenya B, et al. Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania. East African Health Research Journal. 2026;10(2). doi:10.24248/eahrj.v10i2.339

BibTeX
@article{Nkinda2026,
  author = {Nkinda, Lilian and Lyamuya, Eligius and Ueno, Takamasa and Senkoro, Mbazi and Mfinanga, Sayoki and Kidenya, Benson and Kisuse, Juma and Hassan, Frank Eric and Kamori, Doreen and Nkuwi, Emmanuel and Barabona, Godfrey and Masoud, Salim and Shayo, Victoria and Balandya, Emmanuel},
  title = {Neutralising Antibodies Response Against SARS-CoV-2 Among People Living With HIV in Dar- es-Salaam Tanzania},
  journal = {East African Health Research Journal},
  year = {2026},
  volume = {10},
  number = {2},
  doi = {10.24248/eahrj.v10i2.339}
}
Kostenlos starten →